Study identifier:NIS-NES-DUM-2008/3
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
EPIDEP. Epidemiologic study in bipolar depression: evaluation of the usual clinical practice of Psychiatrists in Spain
bipolar depression
-
No
-
All
378
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Feb 2009 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
Cross-sectional observational, non interventional, multicenter study of retrospective review of clinical records of ambulatory followed up bipolar patients in order to record epidemiological aspects of the course of the disorder, more specifically of bipolar depression episodes and the clinical practices carried out by psychiatrists in Spain in bipolar depressive episodes
Location
Location
Alicante, Spain
Location
Almeria, Spain
Location
Badajoz, Spain
Location
Barcelona, Spain
Location
Bilbao, Vizcaya, Spain
Location
Cadiz, Spain
Location
Cordoba, Spain
Location
Granada, Spain
Arms | Assigned Interventions |
---|---|
1 Ambulatory bipolar I and II patients, clinically stabilized for at least the two months prior to recruitment and who had at least one acute episode (depressive, manic, hypomanic or mixed) within the year prior to recruitment. | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.